No hope for the Irrelevance Claim
نویسندگان
چکیده
منابع مشابه
the application of multivariate probit models for conditional claim-types (the case study of iranian car insurance industry)
هدف اصلی نرخ گذاری بیمه ای تعیین نرخ عادلانه و منطقی از دیدگاه بیمه گر و بیمه گذار است. تعین نرخ یکی از مهم ترین مسایلی است که شرکتهای بیمه با آن روبرو هستند، زیرا تعیین نرخ اصلی ترین عامل در رقابت بین شرکتها است. برای تعیین حق بیمه ابتدا می باید مقدار مورد انتظار ادعای خسارت برای هر قرارداد بیمه را برآورد کرد. روش عمومی مدل سازی خسارتهای عملیاتی در نظر گرفتن تواتر و شدت خسارتها می باشد. اگر شر...
15 صفحه اولNO hope for patients with atrial fibrillation.
Atrial fibrillation (AF), either in its paroxysmal or chronic form, is associated with an increased risk of systemic embolization. Currently, the only effective therapy to reduce this risk is long-term systemic anticoagulation. Such treatment comes at a considerable cost; approximately 3% of patients with nonvalvular AF receiving an oral anticoagulant experience major bleeding events that requi...
متن کاملThe purposes of impleader claim
Impleader claim is one of ancillary suits which permit to the parties to implead third person to the action and became that person one of parties. The Iran civil procedure code, unlike some other countries for example Lebanon no attention to purposes of Impleader claim and in Article 135 the subject is expressed in general terms. With attention to generally speaking of this Article and re...
متن کاملSome pain, no gain: experiences with the no-claim rebate in the Dutch health care system.
To contain expenditures in an increasingly demand driven health care system, in 2005 a no-claim rebate was introduced in the Dutch health insurance system. Since demand-side cost sharing is a very controversial issue, the no-claim rebate was launched as a consumer friendly bonus system to reward prudent utilization of health services. Internationally, the introduction of a mandatory no-claim re...
متن کاملParkinson’s disease: no NOP, new hope
Nociceptin/orphanin FQ (henceforth N/OFQ) is the endogenous ligand of the so-called nociceptin opioid peptide (NOP) receptor, a.k.a. Opioid Receptor Like 1 (ORL1) receptor, a G-protein coupled receptor which couples to Gi/o and intracellular kinases, among which mitogen-activated protein (MAP) kinases [1]. In 2004, we provided the first evidence that N/OFQ might play a role in Parkinson's disea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Philosophical Studies
سال: 2019
ISSN: 0031-8116,1573-0883
DOI: 10.1007/s11098-019-01373-2